bepridil has been researched along with Anoxia-Ischemia, Brain in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gáspár, T | 1 |
| Kis, B | 1 |
| Snipes, JA | 1 |
| Lenzsér, G | 1 |
| Mayanagi, K | 1 |
| Bari, F | 1 |
| Busija, DW | 1 |
1 other study available for bepridil and Anoxia-Ischemia, Brain
| Article | Year |
|---|---|
Neuronal preconditioning with the antianginal drug, bepridil.
Topics: Animals; Bepridil; Brain; Calcium Channel Blockers; Cell Survival; Cells, Cultured; Cerebral Cortex; | 2007 |